Health Care/Hospital

Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies

MELBOURNE, Australia, March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced a strategic partnership designed to fast-track early-phase clinical trials and bring ground...

2026-03-23 14:15 5644

Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

SHANGHAI, March 23, 2026 /PRNewswire/ -- Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life Sciences the rights to commercialize its investigational pr...

2026-03-23 14:02 7214

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset P...

2026-03-23 10:24 4787

SingWealth Holdings Strengthens Community Resilience Through Health, Wealth and Legacy Conversations at Lianhe Zaobao Event

SINGAPORE, March 23, 2026 /PRNewswire/ -- SingWealth Holdings ('SingWealth') recently stepped forward as the lead sponsor for Lianhe Zaobao'sMy Legacy and Living Well held on 21 March 2026, reinforcing the Group's commitment to helping Singaporeans navigate crit...

2026-03-23 10:00 3790

SORTIE Agency Honours Content Innovation with Kam Fan Bronze Award for Heroes in White

Redefining Brand Integration: A Strategic Narrative That Resonates with Audiences and Industry Alike HONG KONG, March 23, 2026 /PRNewswire/ -- SORTIE Agency has emerged as a standout at the 41st Kam Fan Awards, one of the advertising industry's most prestigious annual events, securing a Bronze a...

2026-03-23 09:00 2901

Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026

SHANGHAI, March 20, 2026 /PRNewswire/ -- Angel Yeast (SH600298) showcased its latest yeast protein R&D achievements and progress in global applications at FIC 2026 from March 17-19, 2026, reaffirming its commitment to making high-quality protein accessible to everyon...

2026-03-20 22:52 8132

Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

SHANGHAI, March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 billion, representing a year-on-year increase of 16.5%, and net profit of RMB 0.8270 billion....

2026-03-20 21:21 10966

HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"

Asia's First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HONG KONG, March 20, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy....

2026-03-20 19:10 5675

Manulife Named "Asia's Best Insurance Provider for Wealth Management" by Euromoney

HONG KONG, March 20, 2026 /PRNewswire/ -- Manulife today announced it has been named "Asia's Best Insurance Provider for Wealth Management" at the 2026 Euromoney Private Banking Awards. The award recognizes Manulife's excellence in delivering tailored and innovative wealth and legacy planning sol...

2026-03-20 18:00 8506

Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and strategic progress. Dr. Jay Mei, Antengene's...

2026-03-20 17:14 8396

World Oral Health Day 2026: FDI urges governments to turn UN oral health commitments into action

Landmark UN political declaration recognizes oral health as essential to tackling noncommunicable diseases GENEVA, March 20, 2026 /PRNewswire/ -- On World Oral Health Day  (WOHD), FDI World Dental Federation (FDI) is urging governments to translate the oral h...

2026-03-20 16:30 4170

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs

SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd.  ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had been invited to give a speech at the RNA Leaders Europe Conference in Vienna, Austria on March 19th, one of the top oligonucleot...

2026-03-20 14:44 5662

Professor Chun-Hung Chu: "Protecting Oral Health Is Protecting Quality of Life"

World Oral Health Day 2026:"A Happy Mouth Is… A Happy Life" HONG KONG, March 20, 2026 /PRNewswire/ -- A healthy mouth is the foundation of overall well-being and plays an important role in enhancing quality of life. This year, World Oral Health Day is celebrated under the theme "A Happy Mouth Is...

2026-03-20 13:05 3797

MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences

SINGAPORE, March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Sci...

2026-03-20 11:17 6044

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016

SUZHOU, China, March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific antibody-drug conjugate (ADC) for the treatment of triple-negat...

2026-03-20 10:04 4242

D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session

SHANGHAI, March 20, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (A...

2026-03-20 09:00 6433

Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea

Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-c...

2026-03-20 05:39 4047

ACOH 2026 Early Bird Rate Ends 30 April; Abstract Submission Closes 1 April

KUCHING, Malaysia, March 19, 2026 /PRNewswire/ -- Asia's leading platform on workplace health and safety, the 24th Asian Congress on Occupational Health (ACOH) 2026, is calling on researchers, practitioners, and industry professionals to secure their participation as key deadlines approach. Sche...

2026-03-19 19:26 4394

Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results

Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts Increasing Discovery Efforts to Drive Long-term Value Creation Strong Cash Position Supporting Strategic Priorities Upcoming Conference Calls:  English Session: March 20 at 8:30 p.m. HKT / 8:30 a.m. ET  Chinese Session: March 20 at ...

2026-03-19 19:00 7237

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special Administrative Region of China for the treatment of adult patie...

2026-03-19 18:27 4716
1 ... 20212223242526 ... 541